What Do p16, Ki-67, p53, and HPV Mean on a Pathology Report?

Seeing a list of proteins and viruses on a pathology report—like p16, Ki-67, p53, and HPV—can be confusing and alarming. The most important thing to know is that none of these tests independently mean you have invasive cancer ^[1]. Instead, they are “biomarkers” or special stains that act as supportive clues.

Vaginal “leukoplakia” is simply a descriptive term for a white patch; it is not a specific diagnosis. Pathologists use these stains to support a diagnostic pathway—whether the patch is an inflammatory condition, a low-grade change, a high-grade precancer, or cancer. However, the exact final diagnosis always comes down to morphology (the physical shape and structure of the cells under a microscope) and whether the biopsy sample was large and deep enough to properly evaluate ^[1][2].

p16 and Ki-67: Markers for HPV-Related Changes

White patches can sometimes be a sign of a high-grade, HPV-driven precancer, often called High-Grade Squamous Intraepithelial Lesion (HSIL) or VaIN 2/3. Pathologists use two specific stains to evaluate this:

• p16: High-risk HPV interferes with normal cell cycle controls, causing cells to overproduce the p16 protein. If the pathologist sees a strong, solid pattern of p16 (called “block positivity”) extending through the tissue layers, it strongly supports an HPV-associated high-grade precancer ^[3]. However, p16 is just a guide. A negative p16 result does not automatically overrule a diagnosis if the physical cells clearly look like high-grade VaIN; instead, it prompts the pathologist to double-check the tissue, the stain quality, and other potential causes ^[4]. Because p16 can sometimes be found in non-HPV conditions, it is never used in isolation ^[5].
• Ki-67: This is a marker of cell division (proliferation). In a healthy vaginal lining, only the deepest layer of cells is actively dividing. If Ki-67 staining shows that cells are rapidly dividing in the middle and upper layers of the tissue, it supports the presence of an actively growing lesion ^[3][6]. However, repair processes, inflammation, and reactive changes can also increase cell proliferation, so Ki-67 cannot determine the cause or grade of the lesion by itself.

p53: The Non-HPV Pathway

While most vaginal precancers are HPV-related, some uncommon lesions follow an HPV-independent pathway, sometimes associated with chronic skin conditions ^[7][1].

• p53: This is a protein that normally acts as a quality monitor for cell DNA. A normal result (called “wild-type”) looks like a scattered, uneven staining pattern ^[8]. If the p53 protein is completely missing (a “null pattern”, meaning no staining even where normal control cells stain) or is heavily overproduced in the bottom layers, it serves as an indirect clue that there may be a genetic mutation ^[9][8]. Pathologists check p53 when they suspect a non-HPV pathway, but these patterns can be tricky to read and must always be carefully compared to the tissue’s physical structure ^[10]. An abnormal p53 pattern does not prove a mutation, nor does it diagnose inflammation.

HPV Testing on Tissue

Your doctor may test the biopsy tissue directly for high-risk HPV. It is crucial to understand that a positive HPV test does not prove invasion has occurred. High-risk HPV is found in the vast majority of both preinvasive lesions (VaIN) and most—but not all—invasive vaginal squamous cancers ^[11][5]. Detecting HPV DNA or RNA in a biopsy shows that the virus is present in the specimen, and it supports an HPV-associated process when it matches the visual appearance of the biopsy. However, it does not by itself prove that HPV drove that particular white patch, nor does it establish the grade of the disease ^[5]. Furthermore, a positive HPV result generally cannot determine when the infection was originally acquired.

The Big Picture: Morphology and Biopsy Adequacy are Key

Biomarkers are only supportive tools. A pathologist cannot diagnose invasive cancer just because p16 is positive, Ki-67 is high, or HPV is present. To diagnose invasion, the doctor must physically see abnormal cells showing destructive growth into the supporting tissue beneath the basement membrane (the bottom boundary of the vaginal lining) ^[1].

Crucially, “no invasion identified” on a pathology report is only reassuring if the biopsy sample was deep and wide enough to evaluate the full area. A superficial, fragmented, or tiny biopsy might not be able to rule out deeper invasion ^[2]. If the clinical appearance of the patch does not match the biopsy results, your doctor may recommend deeper sections, expert review, a repeat biopsy, or an excisional procedure ^[2]. The overall physical structure of the tissue—and the adequacy of the sample—are what ultimately determine your final diagnosis and guide your care ^[1].

Glossary of Terms

• Basement membrane: The boundary layer separating the surface lining of the vagina from the deeper supporting tissue.
• Block positivity: A strong, continuous staining pattern (often for p16) that extends through the layers of the tissue.
• HSIL (VaIN 2/3): High-Grade Squamous Intraepithelial Lesion. A precancerous condition where abnormal cells are present but have not invaded deeper tissues.
• Morphology: The physical shape, structure, and arrangement of cells as seen under a microscope.
• Null pattern: A test result where a stain (like p53) is completely absent, even in areas where it should normally be present as a control.
• Wild-type: The normal, expected, and functional version of a gene or protein (often seen as a scattered staining pattern for p53).